Home › Sakit ni Parkinson › Illinois › Chicago

Pag-aaral pangklinika para sa Sakit ni Parkinson sa Chicago, IL

Isang pag-aaral para sa Sakit ni Parkinson ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Chicago. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

Nagre-recruitPhase 2

Northwestern Medical Group, Department of Neurology, Chicago

Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06680830

A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease

Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo

Northwestern University Feinberg School of Medicine Dept of Neurology, Chicago

Edad 30 hanggang 80 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06565195

A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

Nagre-recruitPhase 2/3

Site-027, Chicago

Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06976268

GBPDC: Gut-Brain in PD Consortium Master Protocol

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Rush University, Chicago
University of Chicago, Chicago

Edad 21 hanggang 80 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07567794

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

Nagre-recruitObservasyonal na pag-aaral

Rush University Medical Center, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT02071134

Parkinson's Foundation PD GENEration Genetic Registry

Nagre-recruitObservasyonal na pag-aaral

University of Illinois-Chicago, Chicago
Rush University, Chicago
University of Chicago, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT04994015

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

Nagre-recruitPhase 3

Northwestern University Feinberg School Of Medicine, Chicago

Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07174310

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

Nagre-recruitPhase 3

Parkinson's Disease and Movement Disorders Center at Northwestern Memorial Hospital, Chicago
Rush University Medical Center - Neurology, Chicago

Edad 45 hanggang 75 · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT06944522

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Northwestern University, Chicago

Edad 30 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT04477785

Use of CereGate Therapy for Freezing of Gait in PD

Nagre-recruit

Northwestern University, Chicago

Edad 21 hanggang 80 · Lahat ng kasarian · Na-update May 28, 2026 · NCT05292794

rTMS to Improve Cognition in Parkinson's

Nagre-recruitPhase 1/2

Jesse Brown VA Medical Center, Chicago, IL, Chicago

Edad 50 pataas · Lahat ng kasarian · Na-update Abr 21, 2026 · NCT03836950

Black and African Americans Connections to Parkinson's Disease (BLAAC PD)

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Rush University, Chicago
University of Chicago, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 27, 2026 · NCT06719583

Abbott DBS Post-Market Study of Outcomes for Indications Over Time

Nagre-recruitObservasyonal na pag-aaral

Rush University Medical Center, Chicago

Lahat ng edad · Lahat ng kasarian · Na-update Ene 8, 2026 · NCT04071847

Pag-aaral para sa Sakit ni Parkinson sa ibang lungsod

Iba pang pag-aaral sa Chicago

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.